Study to Evaluate Safety and Biological Activity of TroVax® Vaccine Given in Conjunction With IL-2 to Treat Locally Advanced or Metastatic Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00325507
Recruitment Status : Completed
First Posted : May 12, 2006
Last Update Posted : August 1, 2008
The Methodist Hospital System
ORION Clinical Services
Information provided by:
Oxford BioMedica

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2008
  Actual Study Completion Date : July 2008

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 1, 2012
March 2, 2012
2 May 17, 2012
June 14, 2012
3 November 2, 2012
November 30, 2012